glp-1 and gout Drugs May Raise the Risk of Osteoporosis Gout, Study Suggests glp-1_analogs [TUSOM | Pharmwiki]

Among 1,000 people who received GLP-1 receptor agonists for 2 years, 375 and 318 achieved 10% and 5% weight loss, respectively, vs

Retatrutide targets three different receptors: GLP-1 (helps regulate appetite and blood sugar) GIP (supports insulin response) Glucagon (affects energy use and fat metabolism) By targeting all three, the medication delays how fast your stomach digests food, lowers your appetite, and ultimately reduces how much food you eat

Unlike earlier compounds that target one or two pathways, Retatrutide was designed to influence multiple metabolic mechanisms at the same time

Monitor the timing of your hair loss

Glucagon-Like Peptide 1-Based Therapies for the Treatment of Type 2 Diabetes Mellitus. Edited by David M Nathan and Katya Rubinow, UpToDate, Wolters Kluwer, 9 Nov

Beyond Insulin: Using Ozempic and Other Off-Label Drugs for Type 1 Diabetes What Are The Medications For Type 1 Diabetes